“cell-therapy” Archives

in
Entry Author Date Location
Discovery Labs Converts ex-GSK King of Prussia Site into R&D “Colony” 02/03/20 New York
Advanced Therapies Are Reshaping Biopharma R&D: KPMG Report 01/28/20 National
No More Fish or Fruit: Intrexon Turns SynBio Focus to Human Health 01/02/20 National
Rexgenero CEO Talks Importance of “Dialogue” in Cell Therapy Conversations 01/02/20 National
Cell Reprogramming Startup Bit Bio Inks Pact With Charles River 12/16/19 Boston
Aspen Neuro Bags $6.5M to Test Parkinson’s Disease Stem Cell Therapy 12/12/19 San Diego
Scripps Research, AbbVie Expand Drug Discovery Deal Beyond Cancer 12/10/19 San Diego
ArsenalBio Launches With $85M for “Programmable” T Cell Therapies 10/17/19 San Francisco
Led by Gilead Veteran Riva, Glenmark’s Ichnos Steps Out on Its Own 10/15/19 New York
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone 09/06/19 National
Bayer Buys Out BlueRock, Betting at Least $240M More on Cell Therapy Work 08/08/19 Boston
Sequencing Firm Adaptive’s $300M IPO Comes With Pharma Ambitions 06/27/19 Seattle
Boston Tech Watch: LearnLaunch, Starry, Bodeswell, HqO & Pillo 05/31/19 Boston
With $120M, AlloVir Faces Big Test of Cell Therapy to Fight Infection 05/22/19 Texas
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More 05/17/19 National
ElevateBio Gets $150M to Grow a Crop of Gene & Cell Therapy Startups 05/13/19 Boston
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More 04/26/19 National
Can We Afford to Be Cured? A Conversation With ICER’s Steve Pearson 04/23/19 Boston
Poseida to Advance CAR-T For Myeloma with Novartis-Led $142M Round 04/22/19 San Diego
$100M for Talaris Gives Surgeon a Shot to Reinvent Organ Transplants 04/18/19 Boston
Precision Bio’s IPO Raises $126M for Pipeline of Gene-Edited Drugs 03/27/19 Raleigh Durham
New CRISPR Fight: Old Friends Intellia, Caribou in License Dispute 02/06/19 San Francisco
Genentech, Adaptive Bio Join Forces on Personalized Cancer Drugs R&D 01/04/19 Seattle
San Francisco Biotech: The Next Generation—Photos and Takeaways 12/26/18 San Francisco
Bio Roundup: Eli Lilly Tries Tau, Generic Insulin, NASH Cash & More 12/14/18 National
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More 11/26/18 National
Allogene, Cortexyme & RDMD Headline Xconomy’s Dec. 5 Biotech Forum 11/08/18 San Francisco
Roche and SQZ Biotech Expand R&D Pact in Pursuit of New Cancer Drugs 10/15/18 Boston
Xconomy’s San Francisco Event to Showcase Biotech’s Next Generation 09/13/18 San Francisco
SQZ Biotech Adds $72M as Cell Therapy Investment Keeps Burning Hot 08/08/18 Boston
Page 2 of 4 « previous page · next page »